[EN] OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES<br/>[FR] OXABICYCLOHEPTANES ET OXABICYCLOHEPTÈNES POUR LE TRAITEMENT DU DIABÈTE
申请人:LIXTE BIOTECHNOLOGY INC
公开号:WO2014005084A1
公开(公告)日:2014-01-03
A method of increasing the insulin sensitivity of a mammalian cell by contacting the cell with a protein phosphatase 2A (PP2A) inhibitor having the structure (I).